These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33026351)

  • 1. [Use of « Reference change value » in medical biology: about two examples: total PSA and hemoglobin].
    Bouverot C; Blachier S; Roquigny N; Guerber F
    Ann Biol Clin (Paris); 2020 Oct; 78(5):565-573. PubMed ID: 33026351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The concept of reference change values (RCV). Will it supersede reference intervals?].
    Walz B; Fierz W
    Ther Umsch; 2015 Feb; 72(2):130-5. PubMed ID: 25630296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic tests in urology: percentage of free prostate-specific antigen (PSA).
    Yi Y; Breau RH; Witiuk K; Neuberger MM; Dahm P
    BJU Int; 2013 Apr; 111(4):683-5. PubMed ID: 23106827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine PSA testing: an analysis of the controversy concerning its use.
    Hussain NS
    ScientificWorldJournal; 2005 Feb; 5():147-50. PubMed ID: 15759079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncertainty of measurement for 14 immunoassay analytes: application to laboratory result interpretation.
    Çubukçu HC; Yavuz Ö; Devrim E
    Scand J Clin Lab Invest; 2019; 79(1-2):117-122. PubMed ID: 30626224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From XE-2100 to XN-9000, from SIS Standard to GFHC recommendations for slide review: potential impact on review rate and turnaround time.
    Tamigniau A; Bailly N; Chatelain B; Mullier F
    Ann Biol Clin (Paris); 2017 Jun; 75(3):285-292. PubMed ID: 28540851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer.
    Carobene A; Guerra E; Locatelli M; Cucchiara V; Briganti A; Aarsand AK; Coşkun A; Díaz-Garzón J; Fernandez-Calle P; Røraas T; Sandberg S; Jonker N; Ceriotti F; ;
    Clin Chim Acta; 2018 Nov; 486():185-191. PubMed ID: 30063887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff for abnormal values.
    Crawford ED; Leewansangtong S; Goktas S; Holthaus K; Baier M
    Prostate; 1999 Mar; 38(4):296-302. PubMed ID: 10075009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic significance of prostate-specific antigen velocity at intermediate PSA serum levels in relation to the standard deviation of different test systems.
    Manseck A; Pilarsky C; Froschermaier S; Menschikowski M; Wirth MP
    Urol Int; 1998; 60(1):25-7. PubMed ID: 9519417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy assessment of PSA methods must be based on clinical instead of artificial samples--a response to AW Roddam et al., Ann Clin Biochem 2006; 43: 35-48.
    Stephan C; Semjonow A
    Ann Clin Biochem; 2006 Sep; 43(Pt 5):421-2; author reply 422-3. PubMed ID: 17022888
    [No Abstract]   [Full Text] [Related]  

  • 11. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen.
    Luderer AA; Chen YT; Soriano TF; Kramp WJ; Carlson G; Cuny C; Sharp T; Smith W; Petteway J; Brawer MK
    Urology; 1995 Aug; 46(2):187-94. PubMed ID: 7542820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation of free and total prostate-specific antigen levels: the effect on the percent free/total prostate-specific antigen.
    Nixon RG; Lilly JD; Liedtke RJ; Batjer JD
    Arch Pathol Lab Med; 1997 Apr; 121(4):385-91. PubMed ID: 9140308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated Cobas Core PSA assays: sensitive, precise, and specific measurement of PSA-total and PSA-total/PSA-free ratio.
    Groche D; Trebo R; Peters I; Pfleiderer P
    Anticancer Res; 1999; 19(4A):2767-70. PubMed ID: 10470238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ratio of gamma-seminoprotein to prostate-specific antigen for the detection of prostate cancer: its discrimination power could be influenced by the assay methods of PSA and/or gamma-seminoprotein.
    Akino H; Suzuki Y; Oyama N; Kanamaru H; Okada K
    Int J Urol; 1999 Sep; 6(9):440-5. PubMed ID: 10510889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential percentage of serum prostate-specific antigen subforms suggests a new way to improve prostate cancer diagnosis.
    Sarrats A; Comet J; Tabarés G; Ramírez M; Aleixandre RN; de Llorens R; Peracaula R
    Prostate; 2010 Jan; 70(1):1-9. PubMed ID: 19670261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraindividual variation of prostate specific antigen measurement and implications for early detection of prostate carcinoma.
    Yan Y
    Cancer; 2001 Aug; 92(4):776-80. PubMed ID: 11550147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Return of experience on the initial audit of Cofrac and projects for the release of results of emergency biological tests.
    Hoffmann P
    Ann Biol Clin (Paris); 2017 Jun; 75(3):268-283. PubMed ID: 28540850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.
    Catalona WJ; Partin AW; Slawin KM; Brawer MK; Flanigan RC; Patel A; Richie JP; deKernion JB; Walsh PC; Scardino PT; Lange PH; Subong EN; Parson RE; Gasior GH; Loveland KG; Southwick PC
    JAMA; 1998 May; 279(19):1542-7. PubMed ID: 9605898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using predictive value, sensitivity and specificity to interpret laboratory tests: PSA for the diagnosis of prostate cancer.
    Ashley T
    J Insur Med; 2005; 37(4):261-3. PubMed ID: 16459948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-individual variation of serum prostate specific antigen levels in men with benign prostate biopsies.
    Boddy JL; Dev S; Pike DJ; Malone PR
    BJU Int; 2004 Apr; 93(6):735-8. PubMed ID: 15049982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.